Company topline results show larger blood-sugar and weight reductions, with more treatment discontinuation at the highest dose; the drug remains investigational. The post Lilly reports retatrutide advantage over Ozempic in diabetes trial appeared first on PakTribune.
GrowthPakistan brings you the latest news to keep an eye on Pakistan’s startup ecosystem. Business keeps you growing when you stay aware of your competitors' moves. GrowthPakistan offers Business, Tech, Global Tech, Global, Auto, and Startup News straight from industries all around the globe. This platform will help you identify upcoming opportunities not only in Pakistan but worldwide.
Email : growthpakistan@gmail.com
Whatsapp : +92320-9497079
© growthpakistan